Scholarly Publications

  1. Kladou E, Strepkos D, Alexandrou M, Mutlu D, Carvalho PEP, Sara JDS, Ser OS, Alaswad K, Basir MB, Khelimskii D, Jaffer FA, Rafeh NA, Chandwaney R, Cevik C, Ahmad Y, Mastrodemos O, Rangan BV, Jalli S, Voudris K, Sandoval Y, Nicholas Burke M, Brilakis ES; PROGRESS‐CTO Investigators. Modification Procedures for Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry. Catheter Cardiovasc Interv. 2025 Dec;106(7):3628-3639. doi: 10.1002/ccd.70228. Epub 2025 Oct 12. PMID: 41077705.
  2. Wu EB, Matsuno S, Nagamatsu W, Kalyanasundaram A, Harding SA, Lo S, Lim ST, Ge L, Chen JY, Luo HJF, Quan J, Lee SW, Kao HL, Tsuchikane E. New Frontiers in Antegrade Wiring From the Asia Pacific Chronic Total Occlusion Club. JACC Asia. 2025 Feb;5(2):219-230. doi: 10.1016/j.jacasi.2024.12.009. Epub 2025 Feb 4. PMID: 39967211; PMCID: PMC11840268.
  3. Rempakos A, Alexandrou M, Mutlu D, Kalyanasundaram A, Ybarra LF, Bagur R, Choi JW, Poommipanit P, Khatri JJ, Young L, Davies R, Benton S, Gorgulu S, Jaffer FA, Chandwaney R, Jaber W, Rinfret S, Nicholson W, Azzalini L, Kearney KE, Alaswad K, Basir MB, Krestyaninov O, Khelimskii D, Abi-Rafeh N, Elguindy A, Goktekin O, Aygul N, Rangan BV, Mastrodemos OC, Al-Ogaili A, Sandoval Y, Burke MN, Brilakis ES. Predicting Successful Chronic Total Occlusion Crossing With Primary Antegrade Wiring Using Machine Learning. JACC Cardiovasc Interv. 2024 Jul 22;17(14):1707-1716. doi: 10.1016/j.jcin.2024.04.043. Epub 2024 Jul 3. PMID: 38970585.
  4. Wu EB*, Kalyanasundaram A*, Brilakis ES, Mashayekhi K, Tsuchikane E; CTO Global Consensus Group. Global Consensus Recommendations on Improving the Safety of Chronic Total Occlusion Interventions. Heart Lung Circ. 2024 Jul;33(7):915-931. doi: 10.1016/j.hlc.2023.11.030. Epub 2024 Jun 4. PMID: 38839467. [*both are first authors]
  5. Rempakos A, Alexandrou M, Mutlu D, Choi JW, Poommipanit P, Khatri JJ, Young L, Dattilo P, Sadek Y, Davies R, Gorgulu S, Jaffer FA, Chandwaney R, Jefferson B, Elbarouni B, Azzalini L, Kearney KE, Alaswad K, Basir MB, Krestyaninov O, Khelimskii D, Aygul N, Abi-Rafeh N, Elguindy A, Goktekin O, Rangan BV, Mastrodemos OC, Al-Ogaili A, Sandoval Y, Burke MN, Brilakis ES, Kalyanasundaram A. Predictors of successful primary antegrade wiring in chronic total occlusion percutaneous coronary intervention. J Invasive Cardiol. 2024 Jun;36(6). doi: 10.25270/jic/23.00305. PMID: 38446022.
  6. Gorgulu S, Kostantinis S, ElGuindy AM, Abi Rafeh N, Simsek B, Rempakos A, Karacsonyi J, Kalay N, Samir A, Jaoudeh FA, Maalouf A, Soylu K, Yildirim U, Tigen MK, Cincin A, Kalyanasundaram A, Aygul N, Altunkeser BB, El Sayed A, Sadek Y, Shelton C, Jbara K, Vemmou E, Nikolakopoulos I, Mastrodemos OC, Rangan BV, Allana SS, Sandoval Y, Burke MN, Brilakis ES, Goktekin O. Contemporary In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions: Insights from the MENATA (Middle East, North Africa, Turkey, and Asia) Chapter of the PROGRESS-CTO Registry. Am J Cardiol. 2023 Nov 1;206:221-229. doi: 10.1016/j.amjcard.2023.08.103. Epub 2023 Sep 15. PMID:
  7. Rempakos A, Simsek B, Kostantinis S, Karacsonyi J, Alaswad K, Mastrodemos OC, Allana S, Sandoval Y, Kalyanasundaram A, Brilakis ES. Assessment of the ERCTO Score for Predicting Success in Retrograde Chronic Total Occlusion Percutaneous Coronary Interventions in the PROGRESS-CTO Registry. J Invasive Cardiol. 2023 Jun;35(6):E294-E296. doi: 10.25270/jic/23.00036. PMID: 37410746.
  8. Kalyanasundaram A, Hira RS, Lombardi WL. Stingray CART (K14 technique): A novel antegrade dissection reentry strategy. Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30547. Epub ahead of print. PMID: 36617386.
  9. Kalyanasundaram A, Seth A. Retrograde CTO PCI-the final frontier-challenges and outcomes. Catheter Cardiovasc Interv. 2022 Jul;100(1):28-29. doi: 10.1002/ccd.30312. PMID: 35819143.
  10. Sanz-Sánchez J, Mashayekhi K, Agostoni P, Egred M, Avran A, Kalyanasundaram A, Garbo R, Colombo A, Regazzoli D, Reimers B, Brilakis ES, Gasparini GL. Device entrapment during percutaneous coronary intervention. Catheter Cardiovasc Interv. 2022 May;99(6):1766-1777. doi: 10.1002/ccd.30160. Epub 2022 Mar 21. PMID: 35312151; PMCID: PMC9544850.
  11. Wu EB, Brilakis ES, Mashayekhi K, Tsuchikane E, Alaswad K, Araya M, Avran A, Azzalini L, Babunashvili AM, Bayani B, Behnes M, Bhindi R, Boudou N, Boukhris M, Bozinovic NZ, Bryniarski L, Bufe A, Buller CE, Burke MN, Buttner A, Cardoso P, Carlino M, Chen JY, Christiansen EH, Colombo A, Croce K, de Los Santos FD, de Martini T, Dens J, di Mario C, Dou K, Egred M, Elbarouni B, ElGuindy AM, Escaned J, Furkalo S, Gagnor A, Galassi AR, Garbo R, Gasparini G, Ge J, Ge L, Goel PK, Goktekin O, Gonzalo N, Grancini L, Hall A, Hanna Quesada FL, Hanratty C, Harb S, Harding SA, Hatem R, Henriques JPS, Hildick-Smith D, Hill JM, Hoye A, Jaber W, Jaffer FA, Jang Y, Jussila R, Kalnins A, Kalyanasundaram A, Kandzari DE, Kao HL, Karmpaliotis D, Kassem HH, Khatri J, Knaapen P, Kornowski R, Krestyaninov O, Kumar AVG, Lamelas PM, Lee SW, Lefevre T, Leung R, Li Y, Li Y, Lim ST, Lo S, Lombardi W, Maran A, McEntegart M, Moses J, Munawar M, Navarro A, Ngo HM, Nicholson W, Oksnes A, Olivecrona GK, Padilla L, Patel M, Pershad A, Postu M, Qian J, Quadros A, Rafeh NA, Råmunddal T, Prakasa Rao VS, Reifart N, Riley RF, Rinfret S, Saghatelyan M, Sianos G, Smith E, Spaedy A, Spratt J, Stone G, Strange JW, Tammam KO, Thompson CA, Toma A, Tremmel JA, Trinidad RS, Ungi I, Vo M, Vu VH, Walsh S, Werner G, Wojcik J, Wollmuth J, Xu B, Yamane M, Ybarra LF, Yeh RW, Zhang Q. Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 Aug 24;78(8):840-853. doi: 10.1016/j.jacc.2021.05.055. PMID: 34412818.
  12. Wu EB, Brilakis ES, Lo S, Kalyanasundaram A, Mashayekhi K, Kao HL, Lim ST, Ge L, Chen JY, Qian J, Lee SW, Harding SA, Tsuchikane E. Advances in CrossBoss/Stingray use in antegrade dissection reentry from the Asia Pacific Chronic Total Occlusion Club. Catheter Cardiovasc Interv. 2020 Dec;96(7):1423-1433. doi: 10.1002/ccd.28607. Epub 2019 Nov 26. PMID: 31769597; PMCID: PMC7754104.
  13. Brilakis ES,…, Kalyanasundaram A…, Rinfret S. Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention. Circulation. 2019 Jul 30;140(5):420-433. doi: 10.1161/CIRCULATIONAHA.119.039797. Epub 2019 Jul 29. PMID: 31356129.
  14. Kalyanasundaram A, Seth A. Chronic total occlusion or non-chronic total occlusion percutaneous coronary intervention: Do myocytes really care? Catheter Cardiovasc Interv. 2019 May 1;93(6):1067-1068. doi: 10.1002/ccd.28275. PMID:31025521.
  15. Bangalore S, Bezerra HG, Rizik DG, Armstrong EJ, Samuels B, Naidu SS, Grines CL, Foster MT, Choi JW, Bertolet BD, Shah AP, Torguson R, Avula SB, Wang JC, Zidar JP, Maksoud A, Kalyanasundaram A, Yakubov SJ, Chehab BM, Spaedy AJ, Potluri SP, Caputo RP, Kondur A, Merritt RF, Kaki A, Quesada R, Parikh MA, TomaC, Matar F, DeGregorio J, Nicholson W, Batchelor W, Gollapudi R, Korngold E,Sumar R, Chrysant GS, Li J, Gordon JB, Dave RM, Attizzani GF, Stys TP, Gigliotti OS, Murphy BE, Ellis SG, Waksman R. The State of the Absorb Bioresorbable Scaffold: Consensus From an Expert Panel. JACC Cardiovasc Interv. 2017 Dec 11;10(23):2349-2359. doi: 10.1016/j.jcin.2017.09.041. PMID: 29216997.
  16. Daniels DV, Banerjee S, Alaswad K, Doing AH, Dattilo PB, Kalyanasundaram A, Spratt JC, Hanratty CG, Strange JW, Walsh S, Lombardi WL, Aaron Grantham J. Safety and efficacy of the hybrid approach in coronary chronic total occlusion percutaneous coronary intervention: The Hybrid Video Registry. Catheter Cardiovasc Interv. 2018 Feb 1;91(2):175-179. doi: 10.1002/ccd.26501. Epub 2017 Nov 29. PMID: 29193753.
  17. Kearney K, Hira RS, Riley RF, Kalyanasundaram A, Lombardi WL. Update on the Management of Chronic Total Occlusions in Coronary Artery Disease. Curr Atheroscler Rep. 2017 Apr;19(4):19. doi: 10.1007/s11883-017-0655-0. PMID: 28315181.
  18. Kalyanasundaram A, Lombardi WL. COMPLICATIONS OF RECANALIZATION OF CHRONIC TOTAL OCCLUSION. Curr Cardiol Rev. 2015 Nov 6;11(4):305-313. doi: 10.2174/1573403X11666150909105725. PMID: 26354515; PMCID: PMC4774634.
  19. Kalyanasundaram A, Lincoff AM; Medscape. Managing adverse effects and drug-drug interactions of antiplatelet agents. Nat Rev Cardiol. 2011 Sep 13;8(10):592-600. doi: 10.1038/nrcardio.2011.128. PMID: 21912415.
  20. Kalyanasundaram A, Scott TD, Blankenship JC. Manual aspiration of iatrogenic embolization through a left internal mammary artery graft. J Invasive Cardiol. 2010 Jul;22(7):E115-8. PMID: 20603511.
  21. Kalyanasundaram A, Berger PB. Routine platelet testing should not be performed on all patients undergoing percutaneous coronary intervention. Circ Cardiovasc Interv. 2010 Jun 1;3(3):284-7; discussion 288. doi: 10.1161/CIRCINTERVENTIONS.110.950972. PMID: 20551395.
  22. Cai Q, Serrano R, Kalyanasundaram A, Shirani J. A preoperative echocardiographic predictive model for assessment of cardiovascular outcome after renal transplantation. J Am Soc Echocardiogr. 2010 May;23(5):560-6. doi: 10.1016/j.echo.2010.03.008. Epub 2010 Apr 10. PMID: 20381999.
  23. Kalyanasundaram A, Qureshi A, Nassef LA, Shirani J. Functional anatomy of normal mitral valve-left ventricular complex by real-time, three-dimensional echocardiography. J Heart Valve Dis. 2010 Jan;19(1):28-34. PMID: 20329487.
  24. Kalyanasundaram A, Berger P. ACP Journal Club. Fractional flow reserve-guided PCI reduced major adverse cardiac outcomes compared with angiography-guided PCI in multivessel CAD. Ann Intern Med. 2009 May 19;150(10):JC5-7. doi: 10.7326/0003-4819-150-10-200905190-02007. PMID: 19451563.
  25. Mascarenhas V, Kalyanasundaram A, Nassef LA, Lico S, Qureshi A. Simultaneous massive pulmonary embolism and impending paradoxical embolism through a patent foramen ovale. J Am Coll Cardiol. 2009 Apr 14;53(15):1338. doi: 10.1016/j.jacc.2008.12.043. PMID: 19358950.
  26. Kalyanasundaram A, Gerhard GS, Skelding KA. Genomics, haplotypes and cardiovascular disease. Future Cardiol. 2007 Nov;3(6):601-10. doi: 10.2217/14796678.3.6.601. PMID: 19804281.
  27. Kalyanasundaram A, Berger P, Kastrati A. Effects of glycoprotein IIb/IIIa blockers. Heart. 2007 Oct;93(10):1293; author reply 1293. PMID: 17890708; PMCID: PMC2000953.
  28. Kalyanasundaram A, Blankenship JC, Berger P, Herrmann H, McClure R, Moliterno D. Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do Tirofiban and ReoPro give similar efficacy trial?). Catheter Cardiovasc Interv. 2007 Apr 1;69(5):623-9. doi: 10.1002/ccd.20963. PMID: 17192960.
  29. Kalyanasundaram A, Blankenship JC, Shirani J. Non-ST segment elevation acute coronary syndromes. South Med J. 2006 Oct;99(10):1053-4. doi: 10.1097/01.smj.0000242744.41605.f7. PMID: 17100021.
  30. Kalyanasundaram A, Elmore JR, Manazer JR, Golden A, Franklin DP, Galt SW, Zakhary EM, Carey DJ. Simvastatin suppresses experimental aortic aneurysm expansion. J Vasc Surg. 2006 Jan;43(1):117-24. doi: 10.1016/j.jvs.2005.08.007. PMID: 16414398.
  31. C. Don, A. Kalyanasundaram, W. Lombardi. Subintimal laser atherectomy for Chronic total occlusion revascularization. J Am Coll Cardiol. 2014;64(11_S) 34 A. Kalyanasundaram, A. Qureshi, L.A. Nassef, J. Shirani. Functional Anatomy of Normal Mitral Valve-Left Ventricular Complex by Real-Time, Three Dimensional Echocardiography. The Journal of Heart Valve Disease 2010; 19:28- 34.
  32. A. Kalyanasundaram, T. Scott, J.C. Blankenship. Use of Manual aspiration catheter in two cases of Distal Embolization into the Left Anterior Descending through the Left Internal Mammary Artery. J Invasive Cardiology 2010;22:E115–E118
  33. A. Kalyanasundaram, P.B. Berger, A. Kastrati. Effects of glycoprotein IIb/IIIa blockers. Heart (Featured Correspondence), October 1, 2007; 93(10): 1293 – 1293.
  34. A. Kalyanasundaram, K.A. Skelding, P.B.Berger. The Value of Registries and the Importance of Evidence-Based Medicine. Journal of Invasive Cardiology. 2006, VOL 18; pages 11F-16F.
  35. J. Shirani. A. Kalyanasundaram. K. Pourmoghadam. Cor Triatriatum (Cardiology – Congenital Heart Disease in the Adult). Medscape E-Medicine.
  36. A. Kalyanasundaram, J.C. Blankenship. Revascularization Procedures In Coronary Artery Disease. Medscape E-Medicine.
  37. A. Kalyanasundaram, J. Shirani. Acute Coronary Syndromes. Medscape E-Medicine.
  38. DE Howard, A Kalyanasundaram. (2003). Hunger Strikes. Macmillan Encyclopedia of Death and Dying. Kastenbaum Robert, ed. (2 vols). New York: Macmillan Reference USA, pp.449-450.
  39. A. Kalyanasundaram, Peter B. Berger. Elective surgery following Percutaneous Coronary Intervention (PCI). Invited publication at ⦁ www.plateletnews.org
  40. Q. Cai, R Serrano, A. Kalyanasundaram, J. Shirani. A Preoperative Echocardiographic Predictive Model for Assessment of Cardiovascular Outcome after Renal Transplantation. J Am Soc Echocardiography (2010)
  41. V.Mascarenhas, A. Kalyanasundaram, et al. Simultaneous Massive Pulmonary Embolism and Impending Paradoxical Embolism Through a Patent Foramen Ovale JACC (corresponding author). J. Am. Coll. Cardiol. 2009;53;1338
  42. A. Kalyanasundaram, S. Kapadia, E.M. Tuzcu, J. Thornton, K. Wolski, S.E. Nissen, S.J. Nicholls. Comparison of fixed treatment targets or proportionate reductions in LDL cholesterol and progression of coronary atherosclerosis in statin treated patients: insights from Intravascular ultrasound. European Heart Journal ( 2010 ) 31, 791
  43. A. Kalyanasundaram, J. Thornton, K. Wolski, S. Kapadia, E.M. Tuzcu, S.E. Nissen, S.J. Nicholls. IVUS (Intravascular ultrasound) correlates with QCA (Quantitative coronary angiography) for the assessment of coronary artery disease atbaseline, but not for serial changes across time. European Heart Journal ( 2010 ) 31, 792
  44. A. Kalyanasundaram; J. Roy; N. Shah; W.Stewart. Electronic Health Record To Predict CHF In Primary Care. Circulation. 2008;118:S_1084-S_1085.
  45. A. Kalyanasundaram, J. Sartorius, T. Scott, J. C. Blankenship. A pooled analysis of 3 trials of bivalirudin versus heparin and glycoprotein IIb/IIIa inhibitors during Percutaneous Coronary Intervention. TCT-184. American Journal of Cardiology. Vol. 102 (8) .
  46. J Mehilli, P B Berger, G Ndrepepa, A Kalyanasundaram, S Schulz, M Seyfarth, A Kastrati, A Schomig. Abciximab for patients undergoing a percutaneous coronary intervention after pretreatment with 600 mg of clopidogrel: meta-analysis of individual patient data from 4 randomized clinical trials. European Heart Journal (2007) 28,193-194.
  47. A. Kalyanasundaram, P.B.Berger, G. Ndrepapa, J. Mehilli, S. Schulz, A. Schomig, A. Kastrati. Correlates of Bleeding after a 600 mg Loading Dose of Clopidogrel, with and without abciximab: A Pooled Analysis of 4 ISAR randomized trials. Circulation. Vol 116, No 16. Sup II. Oct 26, 2007 .
  48. Kalyanasundaram, N. Shah. Variables – continuous or all-or-none. Heart E- pub ⦁ (http://heart.bmj.com/cgi/eletters/92/7/870#1055)⦁
  49. A. Kalyanasundaram, M. Velagapalli. Group B Streptococcus: From the heart to the brain. Journal of General Internal Medicine 20( S1), 243. (Abstract publication)
  50. A. Kalyanasundaram, A. Quiery, K. Gavlick. Myocardial Infarction in a young adult with elevated APTT. Journal of General Internal Medicine 19 (S1), 63.(Abstract publication)
  51. A. Kalyanasundaram, M. Stecker. A Rare cause of Ataxia in the Elderly. Journal of General Internal Medicine 18 (S1), 62-63. (Abstract publication)
  52. A. Kalyanasundaram, R. Meloy, A. Quiery. Plasmablastic Lymphoma in an immunocompetent Elderly Patient. Southern MedicalJournal. 97 (10), S62. (Abstract publication)
  53. A. Kalyanasundaram, M Foltzer, R Gotoff, LA Nassef. Chest Pain and Increased Troponin: Acute Coronary Syndrome? Southern Medical Journal. 97 (10), S44. (Abstractpublication)
  54. M . Velagapalli, A. Kalyanasundaram. A rare cause of chest pain in a young woman. Journal of General Internal Medicine 21 (S4),
  55. (Abstract Publication)
  56. M Velagapalli, A Kalyanasundaram Wegener’s Granulomatosis: A diagnostic Challenge. Journal of General Internal Medicine 21 (S4), 279. (Abstract Publication)
  57. A. Kalyanasundaram, R Gotoff, M Foltzer, A Qureshi, R Storm, J Perruquet. Enterococcal Pacemaker Endocarditis in a Patient on Etanercept. Southern Medical Journal.97 (10), S70. (Abstract publication)
  58. M. Velagapalli, A. Kalyanasundaram. Acute Myocardial Infarction in a Patient receiving Rituximab. Journal of General Internal Medicine 20 (S1), 228-229. (Abstractpublication)
  59. M. Velagapalli, A. Kalyanasundaram. Elevated Ferritin in Fever of Unknown Origin: An Often Subtle Diagnosis (AOSD). Journal of General Internal Medicine 20 (S1), 240. (Abstract publication)

SCHOLARLY PRESENTATIONS
PRESENTATION AT NATIONAL AND INTERNATIONAL MEETINGS

  • Live case operator at TOBI 2022, Milan, Italy
  • Presented on various CTO topics at leading International conferences over the last year in the ASIA-PACIFIC region including CIT 2019,CIT 2017, ASIA PCR 2018 and 2019, TCT 2018 and  2019,TCTAP 2018 and 2019, TCT 2017, TCTAP 2017, 2018 and 2019, Great Wall 2017, OCC 2017,  MyLive 2018 and  2019, MyLive 2017, India Live 2020, India Live 2019, India Live 2018, Bahrain Live 2017 and India Live  2017 China Interventional Therapeutics 2017. 
  • Faculty in “Meet the Masters” on various CTO topics. India Live 2017 – Chaired sessions and presentations on CTOs including “CTO Management through the Hybrid approach with  CrossBoss – Stingray (CB SR)”
  • Presentation at SCAI – Master the Complex, Johannesburg 2017 – on various CTO Topics
  • Presentation at LM and CTO complex at Chennai Live 2017
  • Management of the Impenetrable proximal Cap – Transcatheter Therapeutics (TCT) 2016, Washington DC 
  • Imaging for Chronic Total Occlusions – TCT India 2016 AND Hybrid approach to CTO – a key to “crossing success” – TCT INDIA 2016  
  • Endovascular treatment: Case studies in challenging situations in vascular interventions – India Live 2016
  • Saudi Arabian Cardiac Intervention Society (SACIS) – 2016 Landmark trials – 2015-2016 Cangrelor – debate PCI complications 
  • Indo-Japanese CTO Club meeting 2016 Talk on “Antegrade Dissection re-entry ; From STAR to CrossBoss – Stingray” 
  • “Retrograde CTO complications and management”.
  • CTO of Popliteal artery – Presentation at India Live 2015. 
  • Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention – Where is the Retrograde Wire?. Case presentation at TCT 2014
  • Laser Atherectomy in the Subintimal Space to Facilitate Chronic Total Occlusion Percutaneous Coronary Intervention. Case presentation at TCT 2014 
  • IVUS guided Multivessel Percutaneous Coronary Intervention in a Patient with Acute Kidney Case presentation at TCT 2014 
  • Comparison of fixed treatment targets or proportionate reductions in LDL cholesterol and progression of coronary atherosclerosis in statin treated patients: insights from Intravascular  Presented at European Society of Cardiology Congress 2010. 
  • IVUS (Intravascular ultrasound) correlates with QCA (Quantitative coronary angiography) for the assessment of coronary artery disease at baseline, but not for serial changes across time.Presented at European Society of Cardiology Congress 2010. 
  • Meta-analysis of 64-slice CT scan in comparison with coronary angiography. Presented at SCAI Annual Scientific Sessions in 2009. 
  • Use of Electronic Health Record Data to Predict Diagnosis of CHF in Primary Care Patients. Presented at the Annual Scientific Sessions, American Heart Association 2008. 
  • A pooled analysis of 3 trials of Bivalirudin versus Heparin and Glycoprotein IIb/IIIa inhibitors during Percutaneous Coronary Intervention. Presented at Transcatheter 

Cardiovascular Therapeutics Twentieth Annual Symposium. 2008 

  • Correlates of Bleeding after a 600 mg Loading Dose of Clopidogrel, with and without abciximab: A Pooled Analysis of 4 ISAR randomized trials. Oral presentation at the Annual Scientific Sessions, American Heart Association 2007. 
  • Differential Impact of Telemedicine on Exercise Capacity and Body Composition in Urban and Rural Underserved Populations. Presented at the American College of Cardiology 57th  Annual Scientific Sessions 2008. 
  • Routine stenting of the side branch offers no advantage in bifurcation lesions in the era of drug-eluting stents. Presented at Interventional Cardiology 2008, 23rd Annual International  Symposium, March 9-14, 2008 
  • Early and Routine Invasive Invasive Strategy after Thrombolysis is preferable to a Conservative Strategy in the current era (A Pooled Analysis of 4 Randomized Control 

Trials). Presented at Interventional Cardiology 2008, 23rd Annual International Symposium, March 9- 14, 2008 

  • Functional Anatomy Of Normal Mitral Valve-left Ventricular Complex Defined By Real- time Three-dimensional Echocardiography.Presented at the Fourth Biennial Meeting of The Society for HeartValve Disease. United States. 
  • Double product – Revisited. Presented at Southern MedicalAssociation Annual meeting  
  • Meta-Analysis Of Eight Randomized Clinical Trials Of Carotid Angioplasty With Or Without Stenting Versus Carotid Endarterectomy For Carotid Stenosis.  Presented at the Annual Scientific Sessions, Society of Cardiovascular Angiography and Interventions   
  • Predictors of Ischemic Complications in Patients with de Novo Saphenous Vein Graft Stenosis Undergoing Percutaneous Coronary Intervention – Results from TARGET (Do Tirofiban and ReoPro Give Similar Efficacy Trial). Presented  at the American College of Physicians (ACP) Annual Scientific Session, April 2005. 
  • Adenosine Stress MRI in the detection of coronary arterydisease: Validat ion of qualitative analysis with coronary angiography. Presented at the American College of Physicians (ACP) Annual  Scientific Session, April 2004. 
  • Attitudes and Perceptions of Cardiology Fellows towards Virtual Reality: Results from a Survey Questionnaire on Cardiac Catheterization Simulation Training.  Presented at the 29th Annual Scientific Sessions, Society for Cardiovascular Angiography and Interventions 2006 
  • Mesalamine Induced Pericardial Tamponade in Crohn’s Disease. Presented at the Society of Hospital Medicine (SHM) Annual Meeting2006. 
  • A Rare Cause of Chest Pain in a Young woman. Presented at the Society of General Internal Medicine Annual Meeting 2006. 
  • Wegener’s granulomatosis: A diagnostic challenge. Presented at the Society of General Internal Medicine (SGIM) Annual Meeting 2006
  • Acute Myocardial Infarction in a patient receiving Rituximab. Presented at the Society of Hospital Medicine (SHM) Annual meeting, May 2005. 
  • Elevated Ferritin in Fever of Unknown Origin: An Often Subtle Diagnosis (AOSD). Presented at the SGIM 28 th Annual Meeting, May 2005. 
  • Group B Streptococcus: From the heart to the brain. Presented at the SGIM 28 th Annual Meeting, May 2005. 
  • Plasmablastic Lymphoma in an Immunocompetent Elderly Patient. Presented at the 98th Annual Scientific Assembly of the Southern Medical Association (SMA), November 2004 
  • Enterococcal Pacemaker Endocarditis in a Patient on Etanercept.Presented at the 98th Annual Scientific Assembly of the Southern Medical Association, November 2004 
  • Chest Pain and Increased Troponin: Acute Coronary Syndrome? Presented at the 98th Annual Scientific Assembly of the SouthernMedical Association, November 2004 
  • Myocardial Infarction in a young adult with elevated APTT. Presented at the SGIM 27th Annual Meeting, May 2004 
  • Pheochromocytoma induced Cardiomyopathy: Reversible Entity? Presented at the SHM Annual meeting, April 2004.
  • Purulent Pericarditis in a Patient with Rheumatoid Arthritis on Etanercept. Presented at the Society of Hospital Medicine Annual Meeting, April 2003. Presentation of Scientific papers at Local  Meetings 
  • Too much of a good thing: Primum non nocere. Presented at the Northeast Regional Meeting of the Society of General Internal Medicine at Hershey, PA in March 2006. 
  • A rare cause of cardiomyopathy and arrythmia. Presented at the Northeast Regional Meeting of the Society of Hospital Medicine at Boston, MA in June 2004. 

A Rare cause of Ataxia in the Elderly. Presented at the 2003 SGIM MidAtlantic Meeting,  March 2003. 

Awards, Memberships and Honors:

  • Asia Pacific CTO club director, India
  • Founding member and Course Director, CHIP-CTO India
  • Founding member of IFACI (Indian Foundation for Advanced Cardiac Interventions)
  • Live case operator at 2022 TOBI, Milan, Italy
  • Live case operator at 2023 MLCTO, Nice, France
  • Live Case operator – CTO at IMC Live 2022
  • Live case operator at 2025, 2024, and 2022 MYLIVE, Malaysia
  • Scientific committee member, TOBI 2022
  • Founder and Course Director for CHIP CTO INDIA – 2019, 2020, 2021, 2022 and 2023 – the first Indian conference to focus on CHIP patients, New Delhi, India
  • Course Co-Director for India Live 2019, Mumbai, India
  • Course Co-Director for IJCTO 2019
  • Course Co-Director for Guangzhou CTO course
  • Invited Faculty for CCT Kobe Japan 2018 and 2019
  • Invited Faculty for CTO Club, Japan 2019
  • Invited Faculty for TCTAP 2019
  • Live Case Operator for India Live (CTO) – 2019 and 2018
  • Live Case Operator at various regional CTO congresses most recently at SEOUL CTO CAMP 2019 
  • Live Case Operator at 9th NHC CTO Course, Singapore
  • 2018 Live Case operator – CTO at MyLive 2018 and
  • Live Case operator – CTO at MyLive 2017
  • Invited faculty at TCT-AP 2018, 2019 and 2020 and Chaired Various CTO sessions. Invited Faculty for TCT 2018 
  • Invited International Course Director IJCTO 2018
  • Invited Faculty and moderated CTO sessions at ASIA-PCR 2018 and 2019
  • Course-Director for CTO conference in Guangzhou 2017, 2018 and 2019
  • Invited Faculty for TCT 2017, 2018 and 2019
  • Invited Faculty and chaired sessions (CTO related) and live case operator at INDIA LIVE 2018, 2019 
  • Invited faculty at CTO LM summit 2018, 2019
  • Invited Faculty and live case operator at MYLIVE 2018
  • Invited faculty and live case operator at MYLIVE 2017
  • Invited Faculty and live case operator at Bahrain LIVE 2017
  • Chaired several sessions, debates, multiple live cases in China 2017 including China Interventional Therapeutics 2017, Great wall 2017, OCC 2017. 
  • Invited faculty and Live case Operator at Taiwan Live 2017
  • Invited faculty and Live case Operator for CTO conference in Saudi Arabia 2017 ⦁ Chairperson at India Live 2017 in several CTO sessions.Faculty and Chairperson at India Live 2017 
  • Faculty for Mastering the Complex 2017 at Johannesburg as SCAI Faculty
  • Faculty at Transcatheter Therapeutics (TCT) 2016,2017,2018, 2019, 2020, 2021, 2022, 2023, 2024 and 2025 – Largest Interventional Meeting in the World
  • Chairperson at sessions in India Live 2016
  • Chairperson at India Live CTO talk – Boston Scientific
  • SACIS 2016 as part of International Faculty
  • Faculty for Mastering the Complex 2016 in Hong Kong part of the International Faculty at India Live 2015 
  • Proctored several hundreds of physicians in US, China Hong Kong, India and Bangladesh on HYBRID STRATEGIES for CTO PCI and proctor for Abbott Vascular, Boston Scientific and Asahi Intecc Inc 
  • Laser expert and first US proctor for Spectranetics in the US and INDIA .
  • Member, Absorb (Bioabsorbable Vascular Scaffold) Expert panel
  • Consultant for Abbott Vascular, Boston Scientific, Asahi Intecc, Spectranetics, AstraZeneca
  • Performed first CTO PCI as live case in South Asia – using crossboss-sting ray – 2015 in Bangladesh 
  • Faculty at IJCTO club meeting 2016, 2017, 2018 and 2019 and Performed first CTO PCI using Crossboss-Stingray as a live case in India at IJCTO Club Annual meeting 

(only US operator at the meeting) 

  • Faculty, University of Washington Complex High Risk Indicated PCI course – 2015
  • Invited Faculty for C3 Complex Cardiovascular Catheter Therapeutics – 2015 and 2019
  • Editorial Board of SCAI’s patient/public/health professionals website, www.Seconds Count.org, the preeminent website for patients, their families, and noninterventionalist colleagues who participate in the care of individuals with cardiovascular disease. 
  • Member of the SCAI Interventional career development committee
  • Member of the SCAI International committee
  • Co-Chair of the Research Innovations and Vignettes (RIV) committee for Society of Hospital Medicine 2007-2009 and Moderator of RIV live session in the Annual Sessions of the Society of  Hospital Medicine 2009 
  • Reviewer – scientific abstracts for Society of Cardiovascular Angiography and Interventions (SCAI) Annual Scientific Sessions 2009 
  • Member, Environmental Scanning Work Group, American College of Cardiology 2009- 2011
  • Academic Excellence Award during the year 2005-2006 at Geisinger Medical Center.
  • Obtained funding as the Principle Investigator from Geisinger Committee of Research for studying Echocardiographic Assesment of Functional Mitral Regurgitation in Patients with Dilated, Non ischemic Cardiomyopathy between January 2006 to June 2006 for the amount of  $27,498. 
  • Physician Recognition Award from the AMA.
  • Reviewer and judge for several national and international conferences
  • Reviewer of research method abstracts for the annual SGIM 2007.
  • Reviewer for the clinical vignettes for the annual SGIM 2007 and 2008.
  • Reviewer and judge at the Annual Scientific Sessions, Society of Hospital Medicine 2007, 2008 and 2009
  • 1st prize in poster presentation at Annual Resident ResearchDay, Geisinger Clinic in 2009
  • Won the 2nd prize for Platform presentation at the Research News from the Front: Scholarly Reports from Resident and Faculty Research at Geisinger Medical Center in May 2008. 
  • 2005 – 2009: Member of Institutional Research Review Board. Geisinger Health System
  • 2005- Present: Reviewer for the Southern Medical Journal, Official Publication of the Southern Medical Association
  • 2006 – Present: Reviewer for the Journal of General Internal Medicine. Official Publication of the Society of General Internal Medicine 
  • 2006-present: Reviewer for the American Heart Journal. ·
  • 2004- 2006: Was in the microsystems committee to enable improvement in various clinical processes during Internal  Medicine residency.
  • Sub-investigator in the APPRAISE, AWARE, ISAR REACT 3 and 4, GRAVITAS, ZEUS, US PARACHUTE trials. 
  • Member, SGIM Mid Atlantic Region Speakers Bureau 2008 and 2009
  • Invited Grand rounds in several institutions including Geisinger Medical Center, Danville, PA and Capital Health System, NJ (2008)
  • Awarded ‘fellowship grant’ from Cardiovascular Research Technologies (CRT) 2009.
Enquiry